Drug-resistant tuberculosis
Do you want to receive a message when there is new research on Drug-resistant tuberculosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you receive a notification as soon as new research on Drug-resistant tuberculosis becomes available. View what Premium costs.
Publications and studies (1457)
- Large-Scale Screening of 239 Traditional Chinese Medicinal Plant Extracts for Their Antibacterial Activities against Multidrug-Resistant Staphylococcus aureus and Cytotoxic Activities. (2020/03/04) ♡
- Anionic food color tartrazine enhances antibacterial efficacy of histatin-derived peptide DHVAR4 by fine-tuning its membrane activity. (2020/03/02) ♡
- Treatment of multidrug-resistant pulmonary tuberculosis with delamanid based on Japanese guideline recommendations. (2020/03/01) ♡
- Comparative analysis of genomic variability for drug-resistant strains of Mycobacterium tuberculosis: The special case of Belarus. (2020/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tuberculosis in childhood and adolescence: a view from different perspectives. (2020/03/01) ♡
- Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study. (2020/02/22) ♡
- Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS. (2020/02/20) ♡
- Effect of Natural Phenolics on Pharmacokinetic Modulation of Bedaquiline in Rat to Assess the Likelihood of Potential Food-Drug Interaction. (2020/02/05) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Galactooligosaccharides protects against DSS-induced murine colitis through regulating intestinal flora and inhibiting NF-κB pathway. (2020/02/01) ♡
- Long-Term Effects of Multi-Drug-Resistant Tuberculosis Treatment on Gut Microbiota and Its Health Consequences. (2020/01/30) ♡
- NSC 18725, a Pyrazole Derivative Inhibits Growth of Intracellular Mycobacterium tuberculosis by Induction of Autophagy. (2020/01/28) ♡
- Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Mycobacterium tuberculosis. (2020/01/24) ♡
- The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles. (2020/01/15) ♡
- Digging Deeper to Save the Old Anti-tuberculosis Target: D-Alanine-D-Alanine Ligase With a Novel Inhibitor, IMB-0283. (2020/01/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Closing gaps in the tuberculosis care cascade: an action-oriented research agenda. (2020/01/11) ♡
- Quantitative estimation of isoniazid content in the commercially available and government-supplied formulations. (2020/01/01) ♡
- Design, synthesis and evaluation of the antibacterial activity of new Linezolid dipeptide-type analogues. (2020/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. New potential drug leads against MDR-MTB: A short review. (2020/01/01) ♡
- Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements. (2020/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. NTF-RINT, a new method for the epidemiological surveillance of MDR Mycobacterium tuberculosis L2/Beijing strains. (2020/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Compassionate drug use: Current status in India. (2020/01/01) ♡
- Immune reconstitution inflammatory syndrome in non-HIV patients with tuberculosis. A case series. (2020/01/01) ♡
- Profile of osteoarticular tuberculosis in children. (2020/01/01) ♡
- High prevalence of rifampin-resistant tuberculosis in mountainous districts of India. (2020/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The challenges of tuberculosis control in protracted conflict: The case of Syria. (2020/01/01) ♡
- Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: An interim analysis. (2020/01/01) ♡
- Profile of HIV and multidrug-resistant tuberculosis in orphans living in orphanages in Mumbai, Maharashtra, India. (2020/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. When attacked by a new enemy, do not forget the old ones. A tale of 2 diseases: tuberculosis and COVID-19. (2020/01/01) ♡
- Adverse drug reactions and risk factors for discontinuation of multidrug-resistant tuberculosis regimens in Gujarat, western India. (2020/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB) (2020-11-23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Saliva and Dried Blood Spot Therapeutic Drug Monitoring for MDR-TB in Tanzania (2020-10-30) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis (2020-10-27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Brief Bactericidal Activity of Anti-Tuberculosis Drugs (2020-10-19) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Drug Concentrations in the Treatment of MDR-TB Related to Minimum Inhibitory Concentrations (2020-10-14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prolonged-Use of Inhaled Gaseous Nitric Oxide (gNO) for Adult With Non-Tuberculous Mycobacteria Infection (2020-07-29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation (2020-03-18) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety, Tolerability, Pharmacokinetics and Food Effects Study of PBTZ169 (2020-02-28) ♡
- CD4+ regulatory T cells and CD4+ activated T cells in new active and relapse tuberculosis. (2019/12/31) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Urban-rural disparities in treatment outcomes among recurrent TB cases in Southern Province, Zambia. (2019/12/30) ♡
- Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal. (2019/12/30) ♡
- [Mass spectrometry-based identification of new serum biomarkers in patients with multidrug resistant pulmonary tuberculosis]. (2019/12/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Melatonin and Its Protective Role against Biotic Stress Impacts on Plants. (2019/12/28) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Factors predictive of the success of tuberculosis treatment: A systematic review with meta-analysis. (2019/12/27) ♡
- Publisher Correction: Genomic analysis of the emergence of drug-resistant strains of Mycobacterium tuberculosis in the Middle East. (2019/12/27) ♡
- Intermittent treatment interruption and its effect on multidrug resistant tuberculosis treatment outcome in Ethiopia. (2019/12/27) ♡
- Contact Investigation of Multidrug-Resistant Tuberculosis Patients: A Mixed-Methods Study from Myanmar. (2019/12/26) ♡
- New Napyradiomycin Analogues from Streptomyces sp. Strain CA-271078. (2019/12/26) ♡
- Outcomes of Community-Based Systematic Screening of Household Contacts of Patients with Multidrug-Resistant Tuberculosis in Myanmar. (2019/12/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence. (2019/12/25) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Effectiveness of vitamin D supplementation on the outcome of pulmonary tuberculosis treatment in adults: a meta-analysis of randomized controlled trials. (2019/12/20) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.